• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Systemic availability of oral slow-release morphine in man.

作者信息

Moore R A, McQuay H J, Bullingham R E, Baldwin D, Allen M C

出版信息

Ann Clin Biochem. 1985 May;22 ( Pt 3):226-31. doi: 10.1177/000456328502200303.

DOI:10.1177/000456328502200303
PMID:4026183
Abstract

In a within-patient crossover study on twelve patients we investigated plasma morphine concentrations for 48 hours after administration of intravenous morphine sulphate followed 24 hours later by oral MST Continus [MST]. Patients received either 10 mg i.v. morphine followed by 10 mg MST or 20 mg i.v. morphine followed by 2 X 10 mg MST tablets. Systemic clearance of morphine was low, being about 3 ml/min/kg after both intravenous and oral administration. The ratio of the areas under the concentration-time curve for MST relative to that for i.v. morphine was about 1:1 for 20 mg doses, but was significantly greater than 1:1 for 10 mg doses. The results suggest high oral systemic availability for morphine and low hepatic morphine metabolism.

摘要

相似文献

1
Systemic availability of oral slow-release morphine in man.
Ann Clin Biochem. 1985 May;22 ( Pt 3):226-31. doi: 10.1177/000456328502200303.
2
Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers.口服硫酸吗啡缓释片在志愿者体内的药代动力学及镇痛效果
Br J Anaesth. 1984 Aug;56(8):821-7. doi: 10.1093/bja/56.8.821.
3
The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.吗啡在健康志愿者中静脉注射、口服和颊部给药后的生物利用度和药代动力学。
Br J Clin Pharmacol. 1989 Apr;27(4):499-505. doi: 10.1111/j.1365-2125.1989.tb05399.x.
4
Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients.控释吗啡片(美施康定)在癌症患者中的相对生物利用度。
Br J Anaesth. 1988 Nov;61(5):569-74. doi: 10.1093/bja/61.5.569.
5
Morphine sulphate slow release. Comparison with i.m. morphine for postoperative analgesia.硫酸吗啡缓释片。与肌肉注射吗啡用于术后镇痛的比较。
Br J Anaesth. 1985 Sep;57(9):858-65. doi: 10.1093/bja/57.9.858.
6
Controlled-release morphine tablets. A double-blind trial in dental surgery patients.
Br J Anaesth. 1981 Dec;53(12):1259-64. doi: 10.1093/bja/53.12.1259.
7
First-pass effect of morphine in rats.
J Pharmacol Exp Ther. 1977 Jan;200(1):236-44.
8
Interindividual variation in the ratio between plasma morphine and its metabolites in cancer patients.癌症患者血浆吗啡与其代谢物比例的个体间差异。
Int J Clin Pharmacol Res. 2003;23(2-3):75-82.
9
Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.
Cancer Chemother Pharmacol. 1992;31(3):251-4. doi: 10.1007/BF00685556.
10
Effect of food on the comparative pharmacokinetics of modified-release morphine tablet formulations: Oramorph SR and MST Continus.食物对缓释吗啡片剂剂型(奥施康定控释片和美施康定)相对药代动力学的影响。
Br J Clin Pharmacol. 1996 May;41(5):417-20. doi: 10.1046/j.1365-2125.1996.32810.x.

引用本文的文献

1
A practical approach to improving pain control in cancer patients.改善癌症患者疼痛控制的实用方法。
West J Med. 1987 May;146(5):580-4.